Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,498
Closed -$588K 269
2020
Q3
$588K Sell
12,498
-2,920
-19% -$146K 0.2% 119
2020
Q2
$786K Sell
15,418
-5,452
-26% -$280K 0.29% 87
2020
Q1
$988K Sell
20,870
-6,203
-23% -$331K 0.44% 56
2019
Q4
$1.59M Sell
27,073
-808
-3% -$44.9K 0.5% 45
2019
Q3
$1.49M Sell
27,881
-949
-3% -$48.8K 0.49% 50
2019
Q2
$1.44M Sell
28,830
-646
-2% -$32.4K 0.46% 54
2019
Q1
$1.54M Buy
29,476
+3,547
+14% +$177K 0.51% 44
2018
Q4
$1.24M Sell
25,929
-3,827
-13% -$188K 0.44% 55
2018
Q3
$1.49M Sell
29,756
-410
-1% -$20.8K 0.48% 50
2018
Q2
$1.52M Sell
30,166
-6,163
-17% -$310K 0.51% 55
2018
Q1
$1.77M Buy
36,329
+13,919
+62% +$648K 0.59% 48
2017
Q4
$994K Sell
22,410
-15,454
-41% -$714K 0.33% 79
2017
Q3
$1.92M Buy
37,864
+7,865
+26% +$399K 0.65% 31
2017
Q2
$1.62M Buy
29,999
+4,845
+19% +$258K 0.56% 39
2017
Q1
$1.33M Buy
25,154
+3,171
+14% +$161K 0.49% 53
2016
Q4
$1.06M Sell
21,983
-13,671
-38% -$675K 0.41% 62
2016
Q3
$1.92M Sell
35,654
-5,133
-13% -$281K 0.75% 31
2016
Q2
$2.21M Buy
40,787
+1,774
+5% +$93.5K 0.91% 25
2016
Q1
$1.98M Buy
39,013
+7,430
+24% +$370K 0.88% 30
2015
Q4
$1.59M Buy
+31,583
New +$1.61M 0.77% 31

Other funds holding GSK

WrapManager Inc's GSK Position: Q4 2020 in Review

WrapManager Inc sold out of GSK (GSK) in Q4 2020, closing a stake of 12,498 shares — an estimated $588K sold.

WrapManager Inc first reported a position in GSK in Q4 2015 and held it in 20 quarters. The position peaked at $2.21M in Q2 2016. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • WrapManager Inc reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • WrapManager Inc sold 12,498 GSK shares in Q4 2020, an estimated $588K.
  • WrapManager Inc first reported a position in GSK in Q4 2015 and held it in 20 quarters.
  • WrapManager Inc's GSK position peaked at $2.21M in Q2 2016.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on WrapManager Inc's 13F filing for Q4 2020, filed 8 Feb 2021.